The iCHOR iDVT venous reperfusion system has demonstrated consistent safety, efficacy, and procedural performance across a diverse spectrum of clinical presentations in limited market release...
Category: For Review
iCHOR Funding Early Commercialization
iCHOR Vascular. Clearing the path As iCHOR Vascular finishes the limited market release (LMR) data and evaluation, we are transitioning into a planned early commercial...
Simplified Mechanical Thrombectomy Opens New Opportunities for ASCs and OBLs
Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs) are emerging as compelling alternatives to hospital-based care, offering patients better access at substantially lower cost. As...
